EPZM

Epizyme Announces CEO Succession

Epizyme Reports Second Quarter 2021 Financial Results and Provides Business Update

Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China

Why Epizyme Stock Is Falling This Week

Epizyme: Potential Comeback With Tazemetostat After Initial Sales Challenge

Epizyme's Multiple Myeloma Drug Candidate Inhibits Tumors In Animal Models